

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.92954227 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.06828365 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.91638176 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.85852923 |
| 5 | leukocyte aggregation (GO:0070486) | 4.50904361 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.45968686 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 4.31585144 |
| 8 | detection of other organism (GO:0098543) | 4.29895733 |
| 9 | respiratory burst (GO:0045730) | 4.27752903 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.22919625 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.22919625 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.20448839 |
| 13 | detection of bacterium (GO:0016045) | 4.17399262 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.14130863 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.14130863 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.14130863 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.14130863 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.14130863 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 4.14130863 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.07604851 |
| 21 | response to peptidoglycan (GO:0032494) | 4.00227365 |
| 22 | T cell migration (GO:0072678) | 3.94368896 |
| 23 | positive regulation of interferon-alpha production (GO:0032727) | 3.93433472 |
| 24 | regulation of interferon-alpha production (GO:0032647) | 3.87023179 |
| 25 | interferon-gamma production (GO:0032609) | 3.85004145 |
| 26 | mast cell activation (GO:0045576) | 3.82928221 |
| 27 | negative thymic T cell selection (GO:0045060) | 3.80216484 |
| 28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.78109868 |
| 29 | negative regulation of cell killing (GO:0031342) | 3.78109868 |
| 30 | neutrophil activation (GO:0042119) | 3.74486246 |
| 31 | granulocyte activation (GO:0036230) | 3.74161644 |
| 32 | negative T cell selection (GO:0043383) | 3.73154758 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.70777393 |
| 34 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.69804649 |
| 35 | cellular response to zinc ion (GO:0071294) | 3.69357049 |
| 36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.68313542 |
| 37 | regulation of B cell differentiation (GO:0045577) | 3.64749854 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.64716682 |
| 39 | detection of external biotic stimulus (GO:0098581) | 3.62327017 |
| 40 | defense response to protozoan (GO:0042832) | 3.58770762 |
| 41 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.57014745 |
| 42 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.53163629 |
| 43 | positive thymic T cell selection (GO:0045059) | 3.53048046 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.49602079 |
| 45 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.48458219 |
| 46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.48402067 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.48036792 |
| 48 | B cell receptor signaling pathway (GO:0050853) | 3.47044312 |
| 49 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45913685 |
| 50 | cellular response to type I interferon (GO:0071357) | 3.44926984 |
| 51 | type I interferon signaling pathway (GO:0060337) | 3.44926984 |
| 52 | response to type I interferon (GO:0034340) | 3.44494675 |
| 53 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.42407764 |
| 54 | T cell selection (GO:0045058) | 3.40264363 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.39935413 |
| 56 | regulation of tolerance induction (GO:0002643) | 3.38601540 |
| 57 | macrophage activation involved in immune response (GO:0002281) | 3.38054382 |
| 58 | positive regulation of antigen processing and presentation (GO:0002579) | 3.37611009 |
| 59 | detection of molecule of bacterial origin (GO:0032490) | 3.35635576 |
| 60 | cellular extravasation (GO:0045123) | 3.35548425 |
| 61 | response to protozoan (GO:0001562) | 3.35170217 |
| 62 | B cell mediated immunity (GO:0019724) | 3.35018702 |
| 63 | positive regulation of mast cell activation (GO:0033005) | 3.34950628 |
| 64 | positive regulation of B cell differentiation (GO:0045579) | 3.34017067 |
| 65 | response to host immune response (GO:0052572) | 3.32915754 |
| 66 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.32915754 |
| 67 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.31463502 |
| 68 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.31251765 |
| 69 | myeloid dendritic cell activation (GO:0001773) | 3.30433213 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.28458558 |
| 71 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.28384448 |
| 72 | cellular response to interferon-beta (GO:0035458) | 3.27205188 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.26614542 |
| 74 | microglial cell activation (GO:0001774) | 3.26529736 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.22149522 |
| 76 | detection of biotic stimulus (GO:0009595) | 3.21151477 |
| 77 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.20545444 |
| 78 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.20545444 |
| 79 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.20321709 |
| 80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.20154252 |
| 81 | regulation of regulatory T cell differentiation (GO:0045589) | 3.18673135 |
| 82 | cellular response to interleukin-15 (GO:0071350) | 3.17205128 |
| 83 | tolerance induction (GO:0002507) | 3.12700147 |
| 84 | response to interleukin-15 (GO:0070672) | 3.12123065 |
| 85 | positive regulation of B cell mediated immunity (GO:0002714) | 3.10272215 |
| 86 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.10272215 |
| 87 | positive regulation of isotype switching (GO:0045830) | 3.10000319 |
| 88 | myeloid dendritic cell differentiation (GO:0043011) | 3.09490407 |
| 89 | positive regulation of interleukin-2 production (GO:0032743) | 3.07390776 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.07161422 |
| 91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.06815024 |
| 92 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.04698691 |
| 93 | leukocyte cell-cell adhesion (GO:0007159) | 3.04322670 |
| 94 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.03371761 |
| 95 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.03274278 |
| 96 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.02100769 |
| 97 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.01579677 |
| 98 | positive regulation of mast cell degranulation (GO:0043306) | 3.01469731 |
| 99 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.01469731 |
| 100 | negative regulation of interleukin-12 production (GO:0032695) | 3.00393775 |
| 101 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.99728001 |
| 102 | macrophage activation (GO:0042116) | 2.99268855 |
| 103 | response to host (GO:0075136) | 2.99019933 |
| 104 | response to host defenses (GO:0052200) | 2.99019933 |
| 105 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99019933 |
| 106 | regulation of antigen processing and presentation (GO:0002577) | 2.98499546 |
| 107 | germinal center formation (GO:0002467) | 2.97375441 |
| 108 | myeloid leukocyte activation (GO:0002274) | 2.97048739 |
| 109 | natural killer cell mediated immunity (GO:0002228) | 2.96470827 |
| 110 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.96470827 |
| 111 | positive regulation of macrophage differentiation (GO:0045651) | 2.95612540 |
| 112 | response to muramyl dipeptide (GO:0032495) | 2.94937412 |
| 113 | regulation of mast cell activation (GO:0033003) | 2.94630114 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.93155881 |
| 115 | negative regulation of innate immune response (GO:0045824) | 2.91997271 |
| 116 | positive regulation of tolerance induction (GO:0002645) | 2.90101881 |
| 117 | thymic T cell selection (GO:0045061) | 2.89520870 |
| 118 | positive regulation of interferon-gamma production (GO:0032729) | 2.89511864 |
| 119 | positive regulation of interferon-beta production (GO:0032728) | 2.88983609 |
| 120 | reactive oxygen species biosynthetic process (GO:1903409) | 2.88923674 |
| 121 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.86769870 |
| 122 | regulation of mast cell degranulation (GO:0043304) | 2.86058607 |
| 123 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.85560985 |
| 124 | leukocyte degranulation (GO:0043299) | 2.84030693 |
| 125 | NIK/NF-kappaB signaling (GO:0038061) | 2.83390713 |
| 126 | regulation of T cell tolerance induction (GO:0002664) | 2.82422996 |
| 127 | superoxide anion generation (GO:0042554) | 2.82360983 |
| 128 | cellular defense response (GO:0006968) | 2.81354764 |
| 129 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.79602213 |
| 130 | positive T cell selection (GO:0043368) | 2.79530975 |
| 131 | leukocyte mediated cytotoxicity (GO:0001909) | 2.76502971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.27774456 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.96358252 |
| 3 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.72369437 |
| 4 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.17947407 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.47565206 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.27564466 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.84217318 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.67087991 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.59782378 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56288717 |
| 11 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.37586243 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32186767 |
| 13 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.30872855 |
| 14 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.16681073 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.94334582 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.61112419 |
| 17 | * MYB_26560356_Chip-Seq_TH2_Human | 2.57106170 |
| 18 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.53499999 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.49641094 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.48235504 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.39224240 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.38344246 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.30699182 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25019875 |
| 25 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.18720356 |
| 26 | * MAF_26560356_Chip-Seq_TH1_Human | 2.15549927 |
| 27 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13980255 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10544834 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.08664742 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04825850 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97366311 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89240610 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88945516 |
| 34 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.86914149 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84714976 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.81386566 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74648351 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.73231050 |
| 39 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.73028654 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72223582 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.65189386 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61791745 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61449623 |
| 44 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.60139795 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54490731 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49770297 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42892171 |
| 48 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37092807 |
| 49 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36920612 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36763482 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36699894 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35906637 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.31036045 |
| 54 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.29397974 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28972044 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28867598 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.28813914 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27228814 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26802454 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26268610 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23015258 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17626570 |
| 63 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16190741 |
| 64 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13937890 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12516697 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11445223 |
| 67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11351778 |
| 68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10912359 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08816099 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06360162 |
| 71 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05638459 |
| 72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03502012 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99741451 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99159814 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95832318 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95650699 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95626910 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94315773 |
| 79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93942873 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91349278 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90853914 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90086984 |
| 83 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88854590 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85409659 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83340172 |
| 86 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82820897 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82085198 |
| 88 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81891373 |
| 89 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80831746 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79774139 |
| 91 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79352908 |
| 92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79213475 |
| 93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78995993 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77256698 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76670646 |
| 96 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.76604317 |
| 97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.75349624 |
| 98 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.75141905 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.74015045 |
| 100 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.73665059 |
| 101 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.72289531 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72163400 |
| 103 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.71207761 |
| 104 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70849408 |
| 105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.69208978 |
| 106 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.68382837 |
| 107 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.65589634 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64222627 |
| 109 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.61337232 |
| 110 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59027646 |
| 111 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.57825520 |
| 112 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.57604830 |
| 113 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.57276864 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56924185 |
| 115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.55544645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.92473310 |
| 2 | MP0005671_abnormal_response_to | 4.07963768 |
| 3 | MP0003436_decreased_susceptibility_to | 3.73524367 |
| 4 | MP0009785_altered_susceptibility_to | 3.69028433 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.50354286 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.46553932 |
| 7 | MP0006082_CNS_inflammation | 3.30376745 |
| 8 | MP0001800_abnormal_humoral_immune | 3.11904558 |
| 9 | MP0005025_abnormal_response_to | 3.10000096 |
| 10 | MP0002419_abnormal_innate_immunity | 3.07179329 |
| 11 | MP0003303_peritoneal_inflammation | 3.02308819 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.99454764 |
| 13 | MP0005387_immune_system_phenotype | 2.97775841 |
| 14 | MP0001790_abnormal_immune_system | 2.97775841 |
| 15 | MP0000685_abnormal_immune_system | 2.97379210 |
| 16 | MP0002723_abnormal_immune_serum | 2.89424257 |
| 17 | MP0003724_increased_susceptibility_to | 2.87756733 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.75392383 |
| 19 | MP0001819_abnormal_immune_cell | 2.75377779 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.54279562 |
| 21 | MP0002405_respiratory_system_inflammati | 2.33251296 |
| 22 | MP0002006_tumorigenesis | 2.25087706 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.21733458 |
| 24 | MP0002398_abnormal_bone_marrow | 2.18723607 |
| 25 | MP0000716_abnormal_immune_system | 2.12666941 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.12466410 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.06875196 |
| 28 | MP0005058_abnormal_lysosome_morphology | 2.04667010 |
| 29 | MP0001853_heart_inflammation | 1.99372171 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.97829647 |
| 31 | MP0004510_myositis | 1.91757731 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.89432238 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.87603726 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.84437771 |
| 35 | MP0004947_skin_inflammation | 1.83054486 |
| 36 | MP0002722_abnormal_immune_system | 1.74089997 |
| 37 | MP0002429_abnormal_blood_cell | 1.73363371 |
| 38 | MP0003448_altered_tumor_morphology | 1.66258785 |
| 39 | MP0008469_abnormal_protein_level | 1.61130682 |
| 40 | MP0000858_altered_metastatic_potential | 1.60765741 |
| 41 | MP0009764_decreased_sensitivity_to | 1.55496027 |
| 42 | MP0000343_altered_response_to | 1.50461768 |
| 43 | MP0005310_abnormal_salivary_gland | 1.48697172 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.46955845 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.44431459 |
| 46 | MP0002933_joint_inflammation | 1.41188903 |
| 47 | MP0001873_stomach_inflammation | 1.38188318 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.36477028 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.30622131 |
| 50 | MP0005451_abnormal_body_composition | 1.29745058 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.26214405 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.26214405 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.24967295 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.23964173 |
| 55 | MP0003866_abnormal_defecation | 1.17485277 |
| 56 | MP0003075_altered_response_to | 1.14886201 |
| 57 | MP0009278_abnormal_bone_marrow | 1.11436780 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.10432020 |
| 59 | MP0005166_decreased_susceptibility_to | 1.07923415 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.05348725 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.03124782 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.00983282 |
| 63 | MP0001851_eye_inflammation | 0.99482763 |
| 64 | MP0000490_abnormal_crypts_of | 0.98822848 |
| 65 | MP0009763_increased_sensitivity_to | 0.91353806 |
| 66 | MP0010307_abnormal_tumor_latency | 0.85249674 |
| 67 | MP0003183_abnormal_peptide_metabolism | 0.83645861 |
| 68 | MP0005390_skeleton_phenotype | 0.82487389 |
| 69 | MP0002019_abnormal_tumor_incidence | 0.79414774 |
| 70 | MP0003045_fibrosis | 0.77201564 |
| 71 | MP0000569_abnormal_digit_pigmentation | 0.76706771 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 0.74547832 |
| 73 | MP0003828_pulmonary_edema | 0.74476293 |
| 74 | MP0000604_amyloidosis | 0.73492300 |
| 75 | MP0000249_abnormal_blood_vessel | 0.70941870 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.70367165 |
| 77 | MP0008004_abnormal_stomach_pH | 0.69827472 |
| 78 | MP0009840_abnormal_foam_cell | 0.68738792 |
| 79 | MP0003795_abnormal_bone_structure | 0.68144738 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.67315522 |
| 81 | MP0003690_abnormal_glial_cell | 0.67071239 |
| 82 | MP0000371_diluted_coat_color | 0.67046048 |
| 83 | MP0003186_abnormal_redox_activity | 0.66122178 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.64565312 |
| 85 | MP0002132_abnormal_respiratory_system | 0.64386000 |
| 86 | MP0008057_abnormal_DNA_replication | 0.64167378 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.62967567 |
| 88 | MP0005164_abnormal_response_to | 0.62247835 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.62162621 |
| 90 | MP0001663_abnormal_digestive_system | 0.60912837 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.60728833 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.60612895 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.60207139 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.58505398 |
| 95 | MP0008873_increased_physiological_sensi | 0.58369348 |
| 96 | MP0008874_decreased_physiological_sensi | 0.57125820 |
| 97 | MP0005023_abnormal_wound_healing | 0.53544908 |
| 98 | MP0004381_abnormal_hair_follicle | 0.52015930 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 0.51342859 |
| 100 | MP0000920_abnormal_myelination | 0.51079994 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.50580399 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.48097378 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.47335865 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.47107984 |
| 105 | MP0004883_abnormal_blood_vessel | 0.45027204 |
| 106 | MP0008260_abnormal_autophagy | 0.44928336 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.44443539 |
| 108 | MP0000609_abnormal_liver_physiology | 0.42759094 |
| 109 | MP0002009_preneoplasia | 0.42377990 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.41432673 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.39187830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.86127847 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.82467582 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.98792428 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.18238020 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.96366438 |
| 6 | Myositis (HP:0100614) | 4.66786483 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.64652347 |
| 8 | Stomatitis (HP:0010280) | 4.61279654 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.36411629 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.35612348 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.18011043 |
| 12 | Obstructive lung disease (HP:0006536) | 4.18011043 |
| 13 | Optic neuritis (HP:0100653) | 4.15251877 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 4.15251877 |
| 15 | Recurrent skin infections (HP:0001581) | 4.11035521 |
| 16 | Orchitis (HP:0100796) | 4.02432051 |
| 17 | Recurrent viral infections (HP:0004429) | 3.78607370 |
| 18 | Vasculitis (HP:0002633) | 3.70891356 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.69933102 |
| 20 | Meningitis (HP:0001287) | 3.69640540 |
| 21 | Gingivitis (HP:0000230) | 3.66480465 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.65971085 |
| 23 | T lymphocytopenia (HP:0005403) | 3.64320788 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.59097042 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.59097042 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 3.54179488 |
| 27 | IgM deficiency (HP:0002850) | 3.53430163 |
| 28 | Recurrent bronchitis (HP:0002837) | 3.48285011 |
| 29 | Increased IgM level (HP:0003496) | 3.36456914 |
| 30 | Abnormality of T cells (HP:0002843) | 3.26311705 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 3.22437096 |
| 32 | Cellulitis (HP:0100658) | 3.20812923 |
| 33 | Chronic otitis media (HP:0000389) | 3.19872963 |
| 34 | Pustule (HP:0200039) | 3.19636216 |
| 35 | Pulmonary infiltrates (HP:0002113) | 3.11373921 |
| 36 | Increased IgE level (HP:0003212) | 3.04189125 |
| 37 | Severe combined immunodeficiency (HP:0004430) | 3.02306488 |
| 38 | Combined immunodeficiency (HP:0005387) | 3.00413171 |
| 39 | IgG deficiency (HP:0004315) | 2.98727333 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.94700243 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.92649539 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.92421056 |
| 43 | Chronic diarrhea (HP:0002028) | 2.83117051 |
| 44 | Thyroiditis (HP:0100646) | 2.82876319 |
| 45 | Recurrent pneumonia (HP:0006532) | 2.82747391 |
| 46 | Lymphopenia (HP:0001888) | 2.82409770 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 2.82047467 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.80751504 |
| 49 | Periodontitis (HP:0000704) | 2.80553783 |
| 50 | Leukocytosis (HP:0001974) | 2.79493219 |
| 51 | Hemoptysis (HP:0002105) | 2.78406505 |
| 52 | Basal ganglia calcification (HP:0002135) | 2.78191250 |
| 53 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.77155693 |
| 54 | Arterial thrombosis (HP:0004420) | 2.73150136 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.72496703 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.67246153 |
| 57 | Gastrointestinal stroma tumor (HP:0100723) | 2.65854699 |
| 58 | IgA deficiency (HP:0002720) | 2.64589670 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.64549479 |
| 60 | Recurrent sinusitis (HP:0011108) | 2.61898099 |
| 61 | Pulmonary embolism (HP:0002204) | 2.60617611 |
| 62 | Abnormality of glycolipid metabolism (HP:0010969) | 2.60413469 |
| 63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.60413469 |
| 64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.60413469 |
| 65 | Inflammation of the large intestine (HP:0002037) | 2.59503973 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.58652808 |
| 67 | Keratoconjunctivitis (HP:0001096) | 2.56139232 |
| 68 | Osteomyelitis (HP:0002754) | 2.53368414 |
| 69 | Encephalitis (HP:0002383) | 2.52551219 |
| 70 | Petechiae (HP:0000967) | 2.51212326 |
| 71 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.50591337 |
| 72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.50329830 |
| 73 | Prolonged bleeding time (HP:0003010) | 2.49680731 |
| 74 | Abnormality of the prostate (HP:0008775) | 2.49528886 |
| 75 | Urticaria (HP:0001025) | 2.49212266 |
| 76 | Recurrent lower respiratory tract infections (HP:0002783) | 2.47917747 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 2.46543217 |
| 78 | Gastrointestinal inflammation (HP:0004386) | 2.44676359 |
| 79 | B lymphocytopenia (HP:0010976) | 2.44103928 |
| 80 | Abnormality of B cell number (HP:0010975) | 2.44103928 |
| 81 | Abnormality of eosinophils (HP:0001879) | 2.43069881 |
| 82 | Eosinophilia (HP:0001880) | 2.42576886 |
| 83 | Anorexia (HP:0002039) | 2.41852738 |
| 84 | Colitis (HP:0002583) | 2.38452848 |
| 85 | Nasal polyposis (HP:0100582) | 2.35573462 |
| 86 | Thrombocytosis (HP:0001894) | 2.33684112 |
| 87 | Dysostosis multiplex (HP:0000943) | 2.33564715 |
| 88 | Disinhibition (HP:0000734) | 2.32884135 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.28552538 |
| 90 | Glomerulonephritis (HP:0000099) | 2.27396691 |
| 91 | Skin rash (HP:0000988) | 2.24112753 |
| 92 | Restrictive lung disease (HP:0002091) | 2.20851295 |
| 93 | Sepsis (HP:0100806) | 2.20338281 |
| 94 | Papilloma (HP:0012740) | 2.19776951 |
| 95 | Verrucae (HP:0200043) | 2.19776951 |
| 96 | Hypochromic anemia (HP:0001931) | 2.19020489 |
| 97 | Gingival bleeding (HP:0000225) | 2.19008597 |
| 98 | Loss of speech (HP:0002371) | 2.16420767 |
| 99 | Hepatosplenomegaly (HP:0001433) | 2.16412260 |
| 100 | Agnosia (HP:0010524) | 2.15735584 |
| 101 | Granulocytopenia (HP:0001913) | 2.15049820 |
| 102 | Epistaxis (HP:0000421) | 2.14906494 |
| 103 | Episodic fever (HP:0001954) | 2.14756323 |
| 104 | Joint swelling (HP:0001386) | 2.13293691 |
| 105 | Glomerulopathy (HP:0100820) | 2.12809687 |
| 106 | Lymphoma (HP:0002665) | 2.12692817 |
| 107 | Gangrene (HP:0100758) | 2.12262132 |
| 108 | Polyneuropathy (HP:0001271) | 2.11723685 |
| 109 | Arthralgia (HP:0002829) | 2.07791916 |
| 110 | Skin ulcer (HP:0200042) | 2.06402580 |
| 111 | Abnormality of the pleura (HP:0002103) | 2.05733284 |
| 112 | Chest pain (HP:0100749) | 2.05400242 |
| 113 | Purpura (HP:0000979) | 2.04399831 |
| 114 | Amaurosis fugax (HP:0100576) | 2.03098339 |
| 115 | Abnormality of the nasal mucosa (HP:0000433) | 2.02847504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.67062149 |
| 2 | MAP4K1 | 4.44320956 |
| 3 | BLK | 3.67921452 |
| 4 | MAP3K14 | 3.58011178 |
| 5 | IRAK4 | 3.20536009 |
| 6 | RIPK4 | 3.09319431 |
| 7 | TBK1 | 2.87959023 |
| 8 | TYK2 | 2.68032958 |
| 9 | JAK3 | 2.65949034 |
| 10 | IKBKE | 2.56491098 |
| 11 | ZAP70 | 2.51688935 |
| 12 | KIT | 2.40136999 |
| 13 | IRAK3 | 2.08814114 |
| 14 | PRPF4B | 2.00940477 |
| 15 | TEC | 1.98757035 |
| 16 | IKBKB | 1.96925735 |
| 17 | JAK1 | 1.93630748 |
| 18 | PBK | 1.93607807 |
| 19 | ITK | 1.93501349 |
| 20 | SYK | 1.89980232 |
| 21 | BTK | 1.85167654 |
| 22 | STK10 | 1.75670886 |
| 23 | CSK | 1.67103784 |
| 24 | CSF1R | 1.65863612 |
| 25 | LCK | 1.56909377 |
| 26 | TGFBR2 | 1.52105401 |
| 27 | LYN | 1.46573688 |
| 28 | HCK | 1.43401928 |
| 29 | PIM2 | 1.43383545 |
| 30 | NME2 | 1.40025631 |
| 31 | MST4 | 1.38578668 |
| 32 | PIM1 | 1.28275401 |
| 33 | CLK1 | 1.27545979 |
| 34 | NEK9 | 1.22376619 |
| 35 | NLK | 1.20252315 |
| 36 | MAP3K13 | 1.19545062 |
| 37 | GRK6 | 1.18539883 |
| 38 | FGFR3 | 1.16719631 |
| 39 | MAP3K3 | 1.16448982 |
| 40 | ERN1 | 1.15023278 |
| 41 | TAOK1 | 1.14437246 |
| 42 | FGFR4 | 1.12781634 |
| 43 | CHUK | 1.11894004 |
| 44 | RPS6KA4 | 1.07465032 |
| 45 | MAP3K12 | 1.03544898 |
| 46 | FES | 1.00103903 |
| 47 | JAK2 | 0.99319171 |
| 48 | MARK3 | 0.98740992 |
| 49 | KDR | 0.97778158 |
| 50 | TESK2 | 0.96708319 |
| 51 | TAOK3 | 0.94601013 |
| 52 | STK4 | 0.94363466 |
| 53 | GRK7 | 0.92690720 |
| 54 | MAP3K1 | 0.91963142 |
| 55 | TAOK2 | 0.91623425 |
| 56 | CDK19 | 0.90768275 |
| 57 | EIF2AK3 | 0.86738668 |
| 58 | LRRK2 | 0.82923549 |
| 59 | PRKCQ | 0.80332414 |
| 60 | MAP2K3 | 0.72386931 |
| 61 | EIF2AK2 | 0.68394591 |
| 62 | FLT3 | 0.68080804 |
| 63 | SIK3 | 0.67710878 |
| 64 | MATK | 0.65903131 |
| 65 | BMPR2 | 0.64593647 |
| 66 | ADRBK2 | 0.64562772 |
| 67 | CAMKK2 | 0.61332995 |
| 68 | EPHB1 | 0.61055710 |
| 69 | MAPK7 | 0.60884441 |
| 70 | TRPM7 | 0.60272362 |
| 71 | IRAK1 | 0.60140064 |
| 72 | MAPK12 | 0.59397090 |
| 73 | MAP3K11 | 0.58520181 |
| 74 | PRKCD | 0.58506146 |
| 75 | MAP3K10 | 0.57460613 |
| 76 | KSR2 | 0.56801675 |
| 77 | CDC42BPA | 0.54157187 |
| 78 | ABL1 | 0.52532771 |
| 79 | PDPK1 | 0.52325134 |
| 80 | FGR | 0.50711827 |
| 81 | YES1 | 0.49168070 |
| 82 | IRAK2 | 0.47741211 |
| 83 | SMG1 | 0.45208120 |
| 84 | HIPK2 | 0.45206181 |
| 85 | CAMKK1 | 0.43082212 |
| 86 | MAP2K6 | 0.42760968 |
| 87 | TNK2 | 0.42457740 |
| 88 | PDK1 | 0.41351812 |
| 89 | EGFR | 0.40400866 |
| 90 | PRKCH | 0.38620795 |
| 91 | MAPKAPK2 | 0.38409986 |
| 92 | PRKD2 | 0.37074950 |
| 93 | TESK1 | 0.37021286 |
| 94 | MARK2 | 0.36105777 |
| 95 | FYN | 0.34895142 |
| 96 | CDK6 | 0.33217646 |
| 97 | IGF1R | 0.32035213 |
| 98 | RPS6KA6 | 0.31749334 |
| 99 | ABL2 | 0.31666537 |
| 100 | CDK4 | 0.31425396 |
| 101 | BMX | 0.31271631 |
| 102 | MAP3K5 | 0.31061276 |
| 103 | EIF2AK1 | 0.30736816 |
| 104 | SIK2 | 0.29689468 |
| 105 | MOS | 0.28031611 |
| 106 | MAP2K2 | 0.26759219 |
| 107 | TLK1 | 0.23185265 |
| 108 | NUAK1 | 0.22699289 |
| 109 | RAF1 | 0.22612881 |
| 110 | PTK6 | 0.22228872 |
| 111 | EPHA3 | 0.21833199 |
| 112 | INSR | 0.21809808 |
| 113 | MAPK4 | 0.20797921 |
| 114 | RPS6KA5 | 0.20657982 |
| 115 | MAP3K8 | 0.20594112 |
| 116 | SCYL2 | 0.20234683 |
| 117 | MAP3K7 | 0.19678261 |
| 118 | ACVR1B | 0.18542169 |
| 119 | STK24 | 0.18286943 |
| 120 | RPS6KC1 | 0.17373165 |
| 121 | RPS6KL1 | 0.17373165 |
| 122 | MAPK11 | 0.17096502 |
| 123 | PIK3CG | 0.16199826 |
| 124 | MAPK3 | 0.14578687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.62298845 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.23291702 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.11508579 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.10788396 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.73093125 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.64742164 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.60312667 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.57715151 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.33146953 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.32727711 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30806516 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.26350161 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.24973484 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.24307828 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.10138969 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.07482280 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.00325287 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99946528 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.95263510 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.92867106 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92510516 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91692910 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.91140964 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.90409787 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.81251059 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74266838 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65323853 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.59502923 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.55252086 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.51330273 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49453941 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47555088 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45857356 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.45555432 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44759174 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42900697 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.42898759 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41902613 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40116757 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36174016 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.24871555 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.22967210 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.19136142 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18115886 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14474845 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.09514451 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06566560 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03460259 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90916949 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89416355 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81305506 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79074585 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73013650 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.72213622 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71194566 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.69813246 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63377011 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62729920 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60080584 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59286772 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54504503 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53382005 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52145772 |
| 64 | Proteasome_Homo sapiens_hsa03050 | 0.52131467 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50988333 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50849425 |
| 67 | DNA replication_Homo sapiens_hsa03030 | 0.50797302 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.47784619 |
| 69 | Base excision repair_Homo sapiens_hsa03410 | 0.47574405 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42139201 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41463223 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39654103 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38871637 |
| 74 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38533282 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38418891 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35804531 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.32659391 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32517178 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31927676 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31601728 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30819685 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29618678 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29597543 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.29397828 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28514661 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26459908 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26445972 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26445714 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25743824 |
| 90 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.25306746 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24445620 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23727306 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23502064 |
| 94 | Homologous recombination_Homo sapiens_hsa03440 | 0.22036984 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20255105 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.19411075 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17264844 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.17190633 |
| 99 | Mismatch repair_Homo sapiens_hsa03430 | 0.16167324 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16156786 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15989164 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15448920 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.15245613 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.14393401 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13740667 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13385375 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.13202768 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.12975031 |
| 109 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.12743357 |
| 110 | Ribosome_Homo sapiens_hsa03010 | 0.12030455 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.11392619 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.11217182 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.10427768 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10029179 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.09410497 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.09176398 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.03957287 |

